• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Brooks Automation Announces Completion of GENEWIZ Acquisition

Share:

November 19, 2018

Brooks Automation, Inc., a leading worldwide provider of automation and cryogenic solutions for multiple markets including semiconductor manufacturing and life sciences, announced today that it has closed its previously announced acquisition of GENEWIZ Group.

GENEWIZ, headquartered in Plainfield, New Jersey, is a leading provider of gene sequencing and synthesis services for more than 4,000 institutional customers worldwide and is supported by their global network of laboratories spanning the United States, China, Japan, Germany and the United Kingdom.

The Company will provide additional information on the GENEWIZ business in their upcoming earnings call on November 19, 2018. Instructions for listening to the call can be found at www.brooks.com/company/investors.

Date: November 19, 2018

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: Cision

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • More M&A Activity Expected Around AAV-Based Gene Therapies, Analyst SaysMore M&A Activity Expected Around AAV-Based Gene Therapies, Analyst Says
  • Caribou Biosciences Raises $125M Via Equity Just One Week After Pfizer Invested $25MCaribou Biosciences Raises $125M Via Equity Just One Week After Pfizer Invested $25M
  • Cadence Neuroscience Secures $15 Million in Series A Financing for Commercialization of Epilepsy Therapy Licensed from Mayo ClinicCadence Neuroscience Secures $15 Million in Series A Financing for Commercialization of Epilepsy Therapy Licensed from Mayo Clinic
  • EmCyte Announces the Acquisition of the Centrepid Platelet ConcentratorEmCyte Announces the Acquisition of the Centrepid Platelet Concentrator
  • Veritas Pharma Enters into Agreement to Secure ACMPR License and Cannabis Growing FacilityVeritas Pharma Enters into Agreement to Secure ACMPR License and Cannabis Growing Facility
  • How Big Pharma Plays Games with Drug Patents and How to Combat itHow Big Pharma Plays Games with Drug Patents and How to Combat it
  • Novartis Drops Eye Disease Gene Therapy from $800M Gyroscope AcquisitionNovartis Drops Eye Disease Gene Therapy from $800M Gyroscope Acquisition
  • Covid-19 Impact on Pharmaceutical Contract Manufacturing and Contract Market Anticipated for Progressive Cagr Growth During 2020-2026Covid-19 Impact on Pharmaceutical Contract Manufacturing and Contract Market Anticipated for Progressive Cagr Growth During 2020-2026

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications